| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| The Johns Hopkins Ovarian Cancer Center of Excellence acknowledges and thanks Aventis, Genzyme, GlaxoSmithKline, Oncotech, Ortho Biotech, and The Pam McDonald Fund for their support of this website through provision of unrestricted educational grants. |
|
 |
|
 |
| Group: |
Treatment |
| Message Title: |
intraperitonel (IP) chemotherapy
|
| Posted By: |
barbara
|
| Date Posted: |
September 14, 2005
|
|
Message Body:
I was diagnosed with ovarian cancer in January, 2005. Since my cancer did not appear to originate in the ovaries themselves, but in the peritoneal cavity, it is classed as primary peritoneal cancer.
Debulking surgery was followed by six cycles of IV carboplatin and taxol chemo. I am happy to report that my CA-125 numbers have remained well in the normal range, starting with the third IV treatment of the initial cycle.
Although my CA 125 numbers look good, at secondlook surgery I was found to have remaining microscopic cancer cells and started the IP therapy.
My side effects have been minimal but have included, in addition to the bloating after treatment, abdomimal cramping and increasing fatigue. I am interested in hearing from others regarding their experience with this IP form of chemotherapy.
I feel very fortunate to be receiving treatment at Johns Hopkins.
|
If you wish to reply to this message, you must be a registered member* of this site. Please take a
moment to log in or to sign up for a membership.
* The Ovarian Cancer Survivor Network is a service to ovarian cancer
patients at Johns Hopkins and Franklin Square Center, thus membership is restricted to only these patients.
If you are not a Hopkins or Franklin Square ovarian cancer patient, you can view but not post messages to
the Network.
|
|